title: Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome.
abstract: The purpose of the study was to examine the relationship between the endothelin-1 (ET-1) concentration and the metabolic variables characteristic of the insulin resistance syndrome ([IRS] hyperinsulinemia, insulin resistance, hypertriglyceridemia, low high-density lipoprotein [HDL] cholesterol, visceral obesity, and glycemic abnormalities). The measurement of circulating ET-1 is a well-recognized marker of endothelial atherosclerotic and cardiovascular disease. Two hundred subjects were divided into 3 groups. Group 1 included 50 subjects with impaired glucose tolerance (IGT) or non-insulin-dependent diabetes mellitus (NIDDM) with IRS. Group 2 included 50 subjects with IGT or NIDDM without IRS. Group 3 included 100 normal subjects as controls. ET-1 levels were higher in group 1 versus groups 2 and 3 in women (11.2 +/- 0.7 v 7.9 +/- 0.5 and 6.6 +/- 0.4 pg/mL, P < .01) and men (10.1 +/- 0.6 v 6.5 +/- 0.8 and 7.2 +/- 0.3 pg/mL, P < .01). No differences were found between groups 2 and 3. With simple regression analysis, ET-1 levels significantly correlated with insulin, glycosylated hemoglobin, body weight, waist to hip ratio, and triglyceride values. However, with multiple regression analysis, only triglycerides (P < .009) and glycosylated hemoglobin (P < .001) remained independently correlated with ET-1. In conclusion, this cross-sectional study indicates that glycosylated hemoglobin and triglycerides are independently correlated with ET-1 levels in patients with IRS.
authors.affiliation: Divisione di Medicina, Cattedra di Clinica Medica Generale e Terapia Medica, University of Milano, Istituto di Ricerca e Cura a Carrattere Scientifico H. San Raffaele, Italy.
authors.forename: P M
authors.initials: PM
authors.lastname: Piatti
authors.forename: L D
authors.initials: LD
authors.lastname: Monti
authors.forename: L
authors.initials: L
authors.lastname: Galli
authors.forename: G
authors.initials: G
authors.lastname: Fragasso
authors.forename: G
authors.initials: G
authors.lastname: Valsecchi
authors.forename: M
authors.initials: M
authors.lastname: Conti
authors.forename: F
authors.initials: F
authors.lastname: Gernone
authors.forename: A E
authors.initials: AE
authors.lastname: Pontiroli
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D014280:Triglycerides / Q000097:blood
chemical_list: D001786:Blood Glucose; D002784:Cholesterol; D019332:Endothelin-1; D006442:Glycated Hemoglobin; D014280:Triglycerides